NAMUSCLA est indiqué dans le traitement symptomatique des myotonies dystrophiques chez l’adulte;
eNq1mF1v2jAUhu/5FVHuyQelQKdAtbF2Q1o1Ros27QaZ5FDMgp0e25Tu188hdKOTo7amvoztvOfE5/XjoyTn23XubQAF5azvx0Hke8BSnlF22/enN5fNnn8+aCQrsiEHy7pBFMQt30tzIkTfL2eDORAmgh9XXz6Cfh/QHzS8hM9XkMon65SkefCZiOUVKco1XrLhNPPWIJc86/uFkrtRLxESdRaDe46/REFSSML9yOHsatY+HE/CUuwFqkoAfiHs1igKzEozVYjA5JBIuOX4YJRepLNWr9uJop5VCComILjCFMZELsfINzSDzByJ5AKsgizus2vATQ6yDGIUD1fpWliJkxXZTuBuZE76vZ4dyq1sRs24241Oz+J2N+qcdaxC4cFWmc2jPyIsZietdifudkJgISNrJbRbm2vYUr0BlIFlncYcJckdVYiK4VOvOYqDcPesEzIqipw8BCtR2G4VQaKnATUR3H1I+QU3qBmV6z37T5+pPA9fmfV0TxBHGZeAGnLFZA1ILie2GzHkTMK2vqJ27JPbvRcpiLeT/c2ZmftjNc9paos3DSAFQk4no3q6uQLDByJgiu7I8J2yjN+LtyfOYYUdZV/soGkULTCLZ62zXic+PbU+UD+1nWpunguFvIBQs4iKYxAzYgt+LFy0Q81Sj/50Ys1dS8RTkkNNU9S0ZI725GMP58z17k5UNWEU/XRxY2uVbwrw4Xr3aJSmWf9vke2A7ILy2pi1ib/e5tVpf0G73O6dtOwsjWaYLKUsxLswXBLRFERvVLBAp9A/uHPdNe1OLvaq0anA6Sj1eXUjvrxStofuuWv/2FZ2//6+ZTbGkKjgiDpUfHZG0dHF24P5Xx/rLO3xE5C4C7PrOYmknLnqf9Tc3PwcdRXourJL1HD4uljQmv8otb5MwuofzqCRhOX/m0HjDwPl+Dc=
AuKsk1cttHmdG4KP